The shares of Fortis Healthcare rose by over 1% intraday on Monday’s trading session after the company announced that its subsidiary Fortis Cancer Care has entered into memorandum of understanding to sell its 79.34% stake in Lalitha Healthcare.
The stock was trading higher by 1.45% at Rs 147 per share on BSE at 0951 hours. It opened at Rs 156 per share.It touched its intraday high and low at Rs 147.80 and Rs 145.30 per share, respectively.
It attracted total traded volume of 5,05,944 shares and traded value of Rs 742.52 akh on NSE at 0953 hours.
Its 52 week high stood at Rs 228.95 (May 3, 2017) and 52 week low at Rs 142.15 (July 17, 2017).
Fortis Healthcare is an integrated healthcare delivery service provider. The company is engaged in establishing, maintaining, operating, running, managing or administering hospitals, medicare, healthcare, diagnostic, health aids and research centers..
The stock was trading higher by 1.45% at Rs 147 per share on BSE at 0951 hours. It opened at Rs 156 per share.It touched its intraday high and low at Rs 147.80 and Rs 145.30 per share, respectively.
It attracted total traded volume of 5,05,944 shares and traded value of Rs 742.52 akh on NSE at 0953 hours.
Its 52 week high stood at Rs 228.95 (May 3, 2017) and 52 week low at Rs 142.15 (July 17, 2017).
Fortis Healthcare is an integrated healthcare delivery service provider. The company is engaged in establishing, maintaining, operating, running, managing or administering hospitals, medicare, healthcare, diagnostic, health aids and research centers..
No comments:
Post a Comment